UNI-EN 4:Sopharma monthly December 2015
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 4 | / | 2016 | | ||||||
| Date of issue: | 2016-01-11 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Sopharma monthly December 2015 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD notifies that for December 2015 the Company recorded an increase of sales revenues of 8% compared to the same month of 2014, including 16% increase in domestic sales and 32% increase in export sales. The increase in export sales is mainly due to an increase in sales on the Russian market by 45%. The management has planned to sustain the export activity in the months January and December 2016, as well as to improve the rhythm of sales in Russia in the summer months. Our expectations are for a better performance of our products, if the current macroeconomic environment remain stable. The expected increase for January 2016 is also high, mainly due to the low baseline from 2015, when due to the volatility of the Russian ruble the sales on the Russian market were temporarily stopped. Sales revenues for 2015 decreased by 14% compared to the same period of 2014, including 0.3% increase of domestic sales and a 20% decrease of export sales. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Sopharma monthly December 2015.doc Sopharma monthly December 2015.doc | Sopharma monthly December 2015 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2016-01-11 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 5.2 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
